A Comparison of Atazanavir and Nelfinavir, Each in Combination With 2 NRTIs, in Patients Who Have Failed Treatments Without a Protease Inhibitor

PHASE3TerminatedINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

August 31, 2001

Primary Completion Date

April 30, 2002

Study Completion Date

April 30, 2002

Conditions
HIV Infections
Interventions
DRUG

Atazanavir

DRUG

Nelfinavir mesylate

Trial Locations (62)

10018

Community Research Initiative on AIDS, New York

10019

Saint Luke's - Roosevelt Hosp Ctr, New York

10029

Mount Sinai Med Ctr, New York

10461

Albert Einstein College of Medicine, The Bronx

19102

Hahnemann Univ Hosp, Philadelphia

23666

Hampton Roads Med Specialists, Hampton

27157

Wake Forest Univ School of Medicine, Winston-Salem

28078

Jemsek Clinic, Huntersville

28232

Carolinas Med Ctr, Charlotte

28602

Piedmont Infectious Disease Consultants, Hickory

29203

Univ of South Carolina School of Medicine, Columbia

29414

Ludwig Lettau Private Practice, Charleston

30309

Philip Brachman, Atlanta

30912

Med College of Georgia, Augusta

32701

IDC Research Initiative, Altamonte Springs

33311

North Broward Hosp District / HIV Clinical Research, Fort Lauderdale

33316

Gary Richmond MD, Fort Lauderdale

33462

Larry Bush, Atlantis

33607

Daniel Seekins, Tampa

33614

Infectious Disease Research Inst, Tampa

34205

Bach and Godofsky, Bradenton

34239

Infectious Diseases Associates, Sarasota

44304

Summa Health System, Akron

46202

Division of Inf Diseases/ Indiana Univ Hosp, Indianapolis

48089

Infectious Disease Clinic, Warren

48202

Henry Ford Hosp, Detroit

53203

Wisconsin AIDS Research Consortium, Milwaukee

60612

Cook County Gen Hosp / Division of Infect Diseases, Chicago

63108

Washington Univ School of Medicine, St Louis

70112

Tulane Univ School of Medicine, New Orleans

72205

Health for Life Clinic, Little Rock

74114

Associates in Med and Mental Health, Tulsa

75208

North Texas Center for AIDS & Clinical Research, Dallas

75390

Univ of Texas Southwestern Med Ctr, Dallas

77004

Joseph Gathe, Houston

77030

Univ TX Health Science Ctr, Houston

90048

Tower Infectious Diseases, Los Angeles

92708

Orange County Ctr for Special Immunology, Fountain Valley

94114

HIV Institute / Davies Med Ctr, San Francisco

94118

Kaiser Foundation Hospital, San Francisco

94705

East Bay AIDS Ctr, Berkeley

95825

Kaiser Hospital, Sacramento

97209

Research & Education Group, Portland

02215

Beth Israel Deaconess Med Ctr, Boston

02445

Community Research Initiative of New England, Brookline

01107

CRI - Springfield, Springfield

08244

South Jersey Infectious Diseases Inc, Somers Point

Unknown

Downtown Infectious Diseases Clinic, Vancouver

McMaster Univ Med Ctr, Hamilton

Sunnybrook Health Science Ctr, Toronto

Clinique Medicale du Quartier Latin, Montreal

Clinique Medicale L'Actuele, Montreal

Hospital General De Mexico, Mexico City

Hospital Regional, Mexico City

Instituto Nacional de Enfermedades Respiratorias, Mexico City

Instituto Nacional de la Nutricion, Mexico City

Program on AIDS / Thai Red Cross Society, Bangkok

Ramathibodi Hosp, Bangkok

Siriraj Hosp / Mahidol Univ, Bangkok

Khonkaen Univ, Khonkaen

00732

Ponce School of Medicine, Ponce

00909

Hepatology / Infectious Diseases, Santruce

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT00028067 - A Comparison of Atazanavir and Nelfinavir, Each in Combination With 2 NRTIs, in Patients Who Have Failed Treatments Without a Protease Inhibitor | Biotech Hunter | Biotech Hunter